Activation of he signaling kinases ERK and Src stimulates the proliferation and migration of PDAC cell lines predominantly comprised of differentiated cancer cells and both kinases are among current targets of pancreatic cancer therapy [52, 53]. This evidence concerns the gene SRC and familial pancreatic carcinoma.